D2R awards $10 million to accelerate RNA-based therapies for rare diseases and cancer

Published: 26 March 2025

Montreal, March 26, 2025 – McGill University’s DNA to RNA Initiative (D2R) has awarded over $10 million in funding to support three groundbreaking research projects that will advance RNA-based...

D2R webinar: Opportunities and challenges of Black people in RNA research

Wednesday, February 12, 2025 12:00to13:00

Join us for D2R’s Black History Month webinar: Opportunities and challenges of Black people in RNA research on Wednesday, February 12, 2025 from 12 to 1pm EST./dna-to-rnaCategory: Research and...

McGill awards $500,000 to accelerate Mpox research and vaccine development

Published: 13 February 2025

Montreal, February 13, 2025 – McGill University’s DNA to RNA Initiative (D2R) and McGill Interdisciplinary Initiative in Infection and Immunity (MI4) have awarded $500,000 to fund five high-impact...

D2R awards over $6 million to support Core Platforms

Published: 7 February 2025

The D2R (DNA to RNA) Initiative has awarded more than $6 million to support eight Core Platforms at McGill University and one at the University of British Columbia through its Core Platform...

Industry Insights with etherna

Friday, January 31, 2025 12:00to13:30

On this page: /dna-to-rnaCategory: Research and innovation

CQDM partners with D2R to enhance collaborations among researchers and industry in RNA research

Published: 28 November 2024

Montréal, November 28th – CQDM is proud to announce a strategic partnership with the D2R (DNA to RNA) Initiative at McGill University, aimed at funding translational research projects carried out...

Rapid Response for Mpox Research

  This call for proposal is no longer accepting applications.  In partnership with McGill's Interdisciplinary Initiative in Infection and Immunity (MI4)

Back to top